Current Report Filing (8-k)
26 3월 2022 - 3:12AM
Edgar (US Regulatory)
0001502966
false
0001502966
2022-03-11
2022-03-11
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
|
Date
of Report (Date of earliest event reported): |
|
March
11, 2022 |
|
Digipath,
Inc.
(Exact
name of registrant as specified in charter)
Nevada
|
|
000-54239 |
|
27-3601979
|
(State
or other Jurisdiction of Incorporation or Organization) |
|
(Commission
File Number) |
|
(IRS Employer
Identification No.) |
6450
Cameron Street, Suite 113 Las Vegas, NV |
|
89118 |
(Address
of principal executive offices) |
|
(zip
code) |
(702)
527-2060
(Registrant’s
telephone
number, including area code)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of registrant under any
of the following provisions:
☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
☐ |
Soliciting
material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12(b)) |
|
|
☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
N/A |
|
N/A |
|
N/A |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405)
or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item
8.01. Other Events
On
March 11, 2022, Digipath, Inc. (the “Company”) notified Evio, Inc. of the Company’s termination of the letter of intent
between the Company and Evio, Inc., which had provided for the purchase by the Company of Evio’s controlling interest in C3 Labs,
LLC (“C3 Labs”), a cannabis and hemp testing laboratory based in Berkeley, California.
Prior
to the termination of the letter of intent, the Company had advanced C3 Labs a total of approximately $1,000,000 in secured loans. The
Company is currently in possession of equipment of C3 Labs, which it is in the process of liquidating. The Company anticipates that the
proceeds of such liquidation will be sufficient to repay the Company in full all amounts owed to it by C3 Labs.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
Digipath, Inc. |
|
|
|
|
Date: March 25, 2022 |
|
|
|
|
By:
|
/s/
A. Stone Douglass |
|
A. Stone Douglass |
|
Chief Financial Officer |
Digipath (PK) (USOTC:DIGP)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Digipath (PK) (USOTC:DIGP)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
Digipath Inc (PK) (OTC 시장)의 실시간 뉴스: 최근 기사 0
More Digipath, Inc. News Articles